EUVIMEDObjevte EUVIMED
VergleichsstudieEvaluationsstudieMultizentrische StudieOpen access · CC BY-NC-ND 4.0

Impact of Voxelotor on Red Blood Cell Exchange Therapeutic Procedures: Evaluation of Multi‐Institutional Procedure Data

Sally Campbell-Lee iD, Ming Jin, Lisandro Fortuny, Daniel Sop, Suzanne Thibodeaux iD, Susan D-Roseff

Journal of Clinical Apheresis · 2025

DOI: 10.1002/jca.70033 ↗

At a glance

Vergleichsstudie in Journal of Clinical Apheresis, 2025. Written by Sally Campbell-Lee and 5 co-authors. Institution: Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA. Major MEDLINE topics: Erythrocyte Transfusion, Hemoglobin, Sickle, Pyrazines. Cited 1 times so far (Crossref); 13 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Hemoglobin S (HbS) polymerization inhibitor drugs such as voxelotor can result in a split peak in HbS as well as additional peaks with hemoglobin A in quantitative methods of HbS measurement. It is unclear how these results should be used to make transfusion decisions. The goal of this study is to compare RBC exchange (RBCX) replacement volumes calculated with HbS‐Vox + HbS versus HbS alone. Patients aged 15–58 years who had variant hemoglobin quantitation performed for clinical care purposes with evidence of voxelotor treatment (split peak in HbS and/or additional peaks with hemoglobin A) were identified by investigator review of variant hemoglobin quantitation test results from the clinical laboratory. The RBCX replacement volume calculated with HbS% total (RBCX volume HbS% total) was compared to the RBCX replacement volume calculated with HbS unmod% (RBCX volume HbS unmod%) in each case. The mean difference between RBCX volume total HbS% and RBCX volume HbS% unmod is 398 mL with 95% CI (198, 598) and RBCX volume total HbS is significantly different from RBCX volume HbS unmod ( p value = 0.0006). If the HbS total is not used to calculate RBCX replacement volumes in patients taking voxelotor, there is a significantly lower amount of RBC that would be ordered, which would lead to higher HbS after RBCX. Additional studies regarding the role of transfusion in such patients are necessary.

Subjects

MeSH terms (MEDLINE)

Erythrocyte TransfusionHemoglobin, SicklePyrazinesAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultAnemia, Sickle CellErythrocytesHemoglobin ABenzaldehydesPyrazoles

Author keywords

calculationcomplexesdrughemoglobinquantitationsickletransfusion

Substances

Hemoglobin AHemoglobin, SicklePyrazinesvoxelotorBenzaldehydesPyrazoles

Authors and institutions

  • Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Department of Pathology and Laboratory Medicine, University of California Irvine, Irvine, California, USA.
  • Vitalant, Chicago, Illinois, USA.
  • Division of General Internal Medicine, Virgina Commonwealth University, Richmond, Virginia, USA.
  • Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Pathology, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID profiles: Sally Campbell-Lee, Suzanne Thibodeaux

Cite

APA

Campbell-Lee, S., Jin, M., Fortuny, L., Sop, D., Thibodeaux, S., & D-Roseff, S. (2025). Impact of Voxelotor on Red Blood Cell Exchange Therapeutic Procedures: Evaluation of Multi‐Institutional Procedure Data. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70033

Vancouver

Campbell-Lee S, Jin M, Fortuny L, Sop D, Thibodeaux S, D-Roseff S. Impact of Voxelotor on Red Blood Cell Exchange Therapeutic Procedures: Evaluation of Multi‐Institutional Procedure Data. Journal of Clinical Apheresis. 2025. doi:10.1002/jca.70033

BibTeX
@article{CampbellLee2025,
  author = {Campbell-Lee, Sally and Jin, Ming and Fortuny, Lisandro and Sop, Daniel and Thibodeaux, Suzanne and D-Roseff, Susan},
  title = {Impact of Voxelotor on Red Blood Cell Exchange Therapeutic Procedures: Evaluation of Multi‐Institutional Procedure Data},
  journal = {Journal of Clinical Apheresis},
  year = {2025},
  doi = {10.1002/jca.70033}
}
Start for free →